RetinaDigest

Weekly curated literature from top retina and ophthalmology journals

16 articles
7 categories
🔬

Retinal Detachment & Trauma2 articles

RRD, TRD, giant tears, PVR, ocular trauma, macular hole, ERM

Giant Outer Retinal Tear in Retinoschisis Retinal Detachment.

Shah et al.
Ophthalmol RetinaFeb 21, 2026

Abstract not available — see full article for details.

View full article

Influence of the Baseline Morphologic Stage on Postoperative Visual Acuity and Metamorphopsia Outcomes in Fovea-off Rhegmatogenous Retinal Detachment.

Zhu et al.
RetinaFeb 18, 2026

In fovea-off rhegmatogenous retinal detachment, more advanced baseline morphologic stages are associated with significantly worse postoperative visual acuity and metamorphopsia outcomes at all follow-up timepoints through 12 months.

View full article
🩸

Diabetic Eye Disease1 article

Diabetic retinopathy surgery, DME treatment, tractional complications

Vitreous Cyst from Retinal Hole in Proliferative Diabetic Retinopathy.

Rodrigues Alves et al.
Ophthalmol RetinaFeb 17, 2026

Abstract not available — see full article for details.

View full article
👁️

AMD & Macular Degeneration2 articles

Neovascular AMD, geographic atrophy, submacular hemorrhage

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

Pitcher et al.
JAMA OphthalmolFeb 19, 2026

Rapid resolution of intraretinal and subretinal fluid within 12 weeks of faricimab treatment predicts longer dosing intervals and treatment durability in patients with neovascular age-related macular degeneration.

View full article

Real-World Durability of Aflibercept 8 mg and Faricimab in Initiators Versus Switchers: A Multicenter Retrospective Analysis.

Sather et al.
RetinaFeb 18, 2026

This multicenter retrospective analysis of 10,247 patients found that initiating faricimab or aflibercept 8 mg achieved better treatment durability (10 vs 9 weeks) and anatomical outcomes compared to switching from older anti-VEGF agents.

View full article
🧬

Inherited Retinal Disease1 article

IRDs, gene therapy, retinitis pigmentosa, LCA, Stargardt

Bilateral Macular Cherry-Red Spots in Infantile Sandhoff Disease.

Cui et al.
Ophthalmol RetinaFeb 16, 2026

Abstract not available — see full article for details.

View full article
👶

Pediatric Retina2 articles

ROP, FEVR, Coats disease, retinoblastoma, pediatric vitreoretinal

Safety and Efficiency reducing ROP Guideline sensitivIty: An external validation using a large US-based dataset.

Arnold et al.
Am J OphthalmolFeb 18, 2026

External validation of proposed ROP screening guideline modifications using a large US database showed potential for reducing screening encounters by 2.5-7.8%, but raised safety concerns for Pacific race infants who may require more sensitive screening protocols.

View full article

Early vitrectomy for macular retinoschisis after anti-VEGF therapy in aggressive retinopathy of prematurity.

Zhong et al.
Am J OphthalmolFeb 17, 2026

Abstract not available — see full article for details.

View full article
🔥

Posterior Uveitis4 articles

Posterior uveitis, panuveitis, chorioretinitis, CMV retinitis, ocular inflammation

Intravitreal cotrimoxazole as adjuvant therapy for active ocular toxoplasmosis: a case series and literature review.

Hosseini et al.
J Ophthalmic Inflamm InfectFeb 20, 2026

Abstract not available — see full article for details.

View full article

Ocular Manifestations of Biopsy-Proven B Virus Infection with Central Nervous System Involvement.

Wong et al.
JAMA OphthalmolFeb 19, 2026

This case report documents the first detailed description of bilateral panuveitis secondary to B virus infection, demonstrating that prompt antiviral treatment with ganciclovir can prevent blindness in this rapidly progressive zoonotic disease.

View full article

Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy.

Iaccheri et al.
Ocul Immunol InflammFeb 17, 2026

This retrospective study of 752 patients with ocular inflammation at an Italian referral center found anterior uveitis (56.34%) was most common, with noninfectious etiologies predominating (77.13%) in a primarily middle-aged, female, Caucasian population.

View full article

Impact of Socioeconomic Disadvantage on Clinical Outcomes of Inflammatory Eye Disease Patients Requiring Systemic Immunosuppression.

Trudrung et al.
Ocul Immunol InflammFeb 16, 2026

Socioeconomic disadvantage, measured by Area Deprivation Index (ADI), significantly delays control of ocular inflammation in uveitis patients treated with systemic immunosuppression, with a 10.4% decreased likelihood of control within 12 months for every 10-unit ADI increase.

View full article
🎯

Ocular Oncology4 articles

Uveal melanoma, retinoblastoma, choroidal tumors, ocular metastases

Ultra-Widefield OCTA in Leukemic Optic Infiltration.

Wang et al.
JAMA OphthalmolFeb 19, 2026

Abstract not available — see full article for details.

View full article

Mismatch Repair Deficiency in Benign and Atypical Ocular Sebaceous Neoplasms: Implications for Muir-Torre Screening and Classification.

Jia et al.
Am J OphthalmolFeb 18, 2026

This retrospective study of 14 ocular sebaceous neoplasms found that atypical sebaceous neoplasms and 67% of adenomas were mismatch repair (MMR) deficient, suggesting potential association with Muir-Torre syndrome, while sebaceomas showed no MMR deficiency.

View full article

Epstein-Barr Virus-Associated Primary Vitreoretinal B-Cell Lymphoma in a Patient Receiving Tofacitinib and Methotrexate for Psoriatic Arthritis.

Qin et al.
Ocul Immunol InflammFeb 16, 2026

A 42-year-old patient on tofacitinib and methotrexate for psoriatic arthritis developed EBV-associated primary vitreoretinal B-cell lymphoma presenting as steroid-refractory vitritis, which resolved following diagnostic pars plana vitrectomy without requiring chemotherapy.

View full article

Re: Badalova et al.: At what age could screening for familial retinoblastoma be stopped? Revised Dutch Retrospective Population-based Cohort Study, 1991-2019 (Ophthalmology. 2025;132:1152-1160).

Abbott et al.
OphthalmologyFeb 16, 2026

Abstract not available — see full article for details.

View full article